-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Stoke Therapeutics (STOK)
-
-
-
-
-
-
-
Stoke Therapeutics, Inc. (STOK) Misses Q3 EPS by 7c
-
-
-
-
-
-
-
Stoke Therapeutics (STOK) PT Lowered to $28 at BTIG
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Stoke Therapeutics (STOK)
-
-
-
-
-
-
-
BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho
-
-
-
-
-
-
-
Stoke Therapeutics Inc. (STOK) Appoints Eric Olson as Chief Business Officer
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

